United States · Series B startup

Who invested in Spark Therapeutics

2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 27 Oct 2026

$123Mraised across 2 rounds since 2013, from 2 sources

$50MVenture$73MSeries B
Latest round
Series B, $73MMay 2014
Step-upi
1.5×
Investors
7
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2014
$50MVenture$73MSeries B
First round
Venture, $50M
Oct 2013
Biggest round
$73M
Series B · May 2014
Between rounds
7 months
from the last two

The rounds

  1. May 2014
    Series B$73M6 new

    From a historical funding recordSEC filing: $73M sold, first sale May 2014

  2. Oct 2013
    Venture$50M1 new
    • The Children's Hospital of Philadelphia

    Reported by technical.ly

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

DeerfieldVC firm1round
T. Rowe PricePrivate equity1round
Brookside CapitalHedge fund1round
Rock Springs CapitalHedge fund1round
The Children's Hospital of Philadelphiano record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Spark Therapeutics

Who invested in Spark Therapeutics?

Spark Therapeutics's investors include Wellington Management, Deerfield, Sofinnova Investments, T. Rowe Price and Brookside Capital, and 2 more on record.

How much has Spark Therapeutics raised?

Spark Therapeutics has raised $123M across 2 rounds since 2013.

When did Spark Therapeutics last raise?

Spark Therapeutics's most recent round was a Series B of $73M in May 2014.

What was Spark Therapeutics's biggest round?

Its most recent round, $73M in May 2014, is also its largest on record.

Who backed Spark Therapeutics first?

Spark Therapeutics's first round on record, in Oct 2013, was backed by The Children's Hospital of Philadelphia.

What stage is Spark Therapeutics at?

Spark Therapeutics's latest named round is a Series B, in May 2014.

Where is Spark Therapeutics based?

Spark Therapeutics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.